doi: 10.1016/j.celrep.2014.10.032
If youre interested in learning more and taking better control of your health journey, sign up today at hims.com/weight-loss/waitlist and forhers.com/weight-loss/waitlist
Retinal experts do recommend obtaining a baseline eye exam and considering closer follow-up of patients on GLP-1RAs within the first 12 to 18 months of starting the drug, particularly for those who have more severe DR at baseline, high baseline HbA 1c percentage, and rapid improvement in glycemic control similar to the characteristics of the patients enrolled in SUSTAIN 6
The FDA declared more than a year ago that there was no longer a shortage and, this month, announced it had sent letters to 30 telehealth companies that warned them to stop illegally marketing compounded GLP-1s
However, these results are promising if more studies can replicate [them], she says
So I think the bigger question for the ecosystem and society and for these companies is when those 1.5 million get the notice that they're not going to be able to be accessing their compounded drugs anymore, where are they going to go
